The Influence of Sensory Phenotype on the Risk of Developing Neuropathic Pain
NCT02666456 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1500
Last updated 2016-01-28
Summary
Cross-sectional and longitudinal analysis of the somatosensory phenotype, assessed by quantitative sensory testing (QST) and Information obtained by questionnaires to detect risk factors for neuropathic pain development and chronification in painless and chronic pain patients.
Conditions
- Neuropathic Pain
- Polyneuropathy
- Peripheral Nerve Injury
Interventions
- OTHER
-
QST, Questionnaires
Assessment of sensory phenotype by QST and questionnaires
Sponsors & Collaborators
-
University of Kiel
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-04-30
- Primary Completion
- 2019-03-31
More Related Trials
-
Understanding Risk Factors and Determinants for Neuropathic Pain
NCT02402361 ·Status: COMPLETED
-
Pretreatment Identification of Duloxetine Success in Neuropathic Pain Patients
NCT01363284 ·Status: COMPLETED ·Phase: NA
-
Analysis of Markers in the Blood Correlated With Neuropathic Pain
NCT02208206 ·Status: COMPLETED
-
Efficacy of Etoricoxib on Peripheral Hyperalgesia
NCT01088256 ·Status: TERMINATED ·Phase: PHASE2
-
Analysis of Cortical Excitability in Neuropathic Pain
NCT00789347 ·Status: UNKNOWN
-
Patient Assisted Intervention for Neuropathy: Comparison of Treatment in Real Life Situations
NCT02260388 ·Status: COMPLETED ·Phase: PHASE4
-
A Study of Single Dose Pain Therapy in Patients With Painful Diabetic Neuropathy (0000-115)
NCT00837941 ·Status: WITHDRAWN ·Phase: PHASE2
-
Probing the Role of Sodium Channels in Painful Neuropathies
NCT02243475 ·Status: UNKNOWN
-
Tolerability of Switching to Duloxetine for the Management of Diabetic Nerve Pain
NCT00266643 ·Status: COMPLETED ·Phase: PHASE4
-
An Open-Label Comparison of Duloxetine to Other Alternatives for the Management of Diabetic Peripheral Neuropathic Pain
NCT00385671 ·Status: COMPLETED ·Phase: PHASE4
-
Comparative Study in Patients With Refractory Chronic Lower Limb Neuropathic Pain and/or Back Neuropathic Pain.
NCT04852107 ·Status: TERMINATED ·Phase: NA
-
AZD2066 Neuropathic Pain - Mechanical Hypersensitivity
NCT00939094 ·Status: TERMINATED ·Phase: PHASE2
-
Lidocaine for Diabetic Peripheral Neuropathy
NCT02363803 ·Status: COMPLETED ·Phase: NA
-
Study in Neuropathic Pain Patients With Peripheral Nerve Injury
NCT00969059 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of Celecoxib and Pregabalin Compared With Celecoxib Monotherapy, in Patients With Chronic Low Back Pain Having a Neuropathic Component
NCT01838044 ·Status: TERMINATED ·Phase: PHASE4
-
Safety and Efficacy Study of ADL5859 in Participants With Neuropathic Pain Associated With Diabetic Peripheral Neuropathy
NCT00603265 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Possible Changes in QST After Application of Capsaicin on Patients With Peripheral Neuropathic Pain
NCT01596491 ·Status: COMPLETED
-
Impact of Peripheral Afferent Input on Central Neuropathic Pain
NCT05646810 ·Status: UNKNOWN ·Phase: NA
-
Effect of NRD135S.E1 in Peripheral Neuropathic Pain in Diabetic Patients
NCT02345291 ·Status: COMPLETED ·Phase: PHASE2
-
Microneurographic Assessment of Peripheral Nerves in Healthy Volunteers and Individuals With Sensory Dysfunction Caused by Inherited Mutations in the PIEZO2 Gene
NCT06052631 ·Status: RECRUITING
-
Effects of LY3848575 Versus Placebo in Participants With Painful Distal Sensory Polyneuropathy
NCT06568042 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Exploring the Benefit of Neuromodulation in Treating Chemo-induced Peripheral Neuropathy Using Peripheral Neuropathy Markers (Meissner's Corpuscles and Epidermal Nerve Fiber Density) and Sensory Testing (Quantitative Sensory and Gait Testing): A Single Center Feasibility Study
NCT06121232 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
NS1209 and Lidocaine in Patients With Peripheral Neuropathic Pain
NCT00258622 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of the Effectiveness of Ethosuximide in the Treatment of Peripheral Neuropathic Pain.
NCT02100046 ·Status: COMPLETED ·Phase: PHASE2
-
IVIG in Painful Sensory Neuropathy
NCT06183008 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4